Clinical Study
The Presence of Mutations in the K-RAS Gene Does Not Affect Survival after Resection of Pulmonary Metastases from Colorectal Cancer
Table 2
Univariate association of overall and disease-free survival with other variables studied.
| Variables | Survival (95% CI) | P | DFS (95% CI) | P |
| Previous liver metastasis | | | | | No | 89.2 (74.1–104.2) | 0.064 | 70.2 (55.9–84.5) | 0.017 | Yes | 58.8 (34.4–83.1) | 35.9 (17.5–54.3) | DFI | | | | | <12 m | 63.6 (31.6–75.6) | 0.078 | 39.4 (17.6–61.2) | 0.185 | >12 m | 89.1 (74.3–103.9) | 68.5 (54.5–82.5) | <24 m | 62.5 (47.8–77.1) | 0.450 | 45.5 (31.1–59.8) | 0.509 | >24 m | 89.4 (73.3–105.5) | 69.3 (59.8–84.6) | <36 m | 73.1 (57.3–80.9) | 0.347 | 53.0 (37.8–68.2) | 0.119 | >36 m | 95.3 (74.8–115.7) | 77.5 (57.9–97.2) | <48 m | 79.8 (63.6–95.9) | 0.128 | 58.8 (43.6–74.1) | 0.066 | >48 m | 99.1 (75.8–122.4) | 81.8 (59.2–104.5) | Sex | | | | | Man | 82.5 (67.5–97.6) | 0.512 | 66.2 (50.9–81.5) | 0.634 | Woman | 90.5 (63.9–117.1) | 62.7 (39.5–85.9) | Access | | | | | VATS | 84.4 (37.8–130.9) | 0.880 | 83.1 (37.1–128.9) | 0.685 | Others | 84.2 (70.2–98.2) | 63.4 (50.4–76.4) | Complications | | | | | No | 87.5 (73.2–101.7) | 0.406 | 68.6 (55.1–82.1) | 0.023 | Yes | 46.9 (32.1–61.8) | 27.1 (7.9–46.3) | Postoperative chemotherapy | | | | | No | 51.9 (36.6–67.2) | 0.233 | 33.1 (19.2–46.9) | 0.213 | Yes | 97.6 (81.3–113.9) | 73.7 (58.2–89.3) | Lymph node involvement | | | | | − | 85.8 (72.1–99.6) | 0.008 | 67.5 (54.1–80.9) | 0.001 | + | 61.4 (19.8–102.9) | 38.6 (1.2–75.4) | Size | | | | | <1 cm | 103.3 (83.4–123.3) | 0.057 | 76.2 (48.8–103.7) | 0.198 | >1 cm | 80.0 (66.2–93.8) | 62.2 (48.9–75.4) | Number | | | | | 1 | 95.1 (79.8–110.4) | 0.001 | 74.9 (59.9–89.8) | 0.000 | >1 | 45.9 (29.5–62.4) | 27.3 (16.1–38.5) | Age | | | | | <65 years | 104.3 (83.1–125.5) | 0.053 | 72.4 (51.9–92.8) | 0.527 | >65 years | 70.9 (54.9–86.9) | 59.6 (43.7–75.4) | Comorbidity | | | | | No | 83.7 (61.6–105.8) | 0.033 | 53.4 (35.1–71.6) | 0.040 | Yes | 87.058 (71.8–102.4) | 73.7 (56.7–90.7) | Laterality of the metastases | | | | | Right | 71.4 (59.2–89.6) | 0.113 | 54.2 (39.8–68.7) | 0.050 | Left | 99.5 (75.2–123.3) | 84.0 (61.4–106.7) | Primary | | | | | Rectum | 78.3 (62.0–94.6) | 0.174 | 60.3 (44.5–76.0) | 0.319 | Colon | 91.9 (70.7–113.2) | 71.8 (51.1–92.4) | Preoperative level of CEA | | | | | − | 99.8 (82.4–117.4) | 0.024 | 75.4 (58.2–92.7) | 0.020 | + | 62.8 (41.1–84.6) | 45.9 (25.1–66.9) |
|
|
In all cases, time is measured in months. DFI: disease-free interval; VATS: video-assisted thoracic surgery; CEA: carcinoembryonic antigen.
|